NDAINJECTIONINJECTABLEPriority Review
Approved
Feb 1999
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
4/8 — Partial
Priority Review
FERRLECIT (sodium ferric gluconate complex) by Sanofi. Approved for parenteral iron replacement [epc]. First approved in 1999.
Drug data last refreshed 22h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Ferrlecit is a parenteral iron replacement therapy administered by injection, designed to treat iron deficiency in patients who cannot tolerate oral iron or require rapid iron repletion. It is a small-molecule iron complex that replenishes systemic iron stores in conditions such as chronic kidney disease and iron-deficiency anemia.
LOE Approaching
Approaching loss of exclusivity signals declining revenue and likely reduced commercial team headcount; typical small-molecule erosion of 80–90% in first 12 months post-LOE.
Mechanism of Action
Pharmacologic Class:
Parenteral Iron Replacement
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.
Started Dec 2003
112 enrolled
Anemia
Career Relevance
Ferrlecit roles carry limited career advancement potential due to approaching loss of exclusivity and zero linked open positions. Professionals on this brand should anticipate transition opportunities or internal mobility to growth-stage products within Sanofi's portfolio.
Brand Manager
Worked on FERRLECIT at Sanofi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.